Copy of Is 2017 a Do-Or-Die Year for Aurora Cannabis Stock?

Is 2017 a Do-Or-Die Year for Aurora Cannabis Stock? By Stephen Karmazyn 15, 2016 What’s Next for Aurora Cannabis Stock? Aurora Cannabis Inc (CVE:ACB) has both reasons to be excited and reasons to be apprehensive about marijuana legalization prospects moving forward. Aurora Cannabis stock was down five percent on Wednesday, despite having gained six percent the day after the federal government’s task force released recommendations concerning the pot regulation process.

Society for Neuroscience: Medical Marijuana Research

The Society for Neuroscience Annual Meeting was held last month in San Diego. More than 30,000 neuroscientists were in attendance. They featured talks and presentations from scientists across the research spectrum. This is the largest source of contemporary brain research in the world today.

Capitalizing With Cannabis

Despite favorable state-wide election results, concerns among cannabis investors have increased and cannabis stocks continue to move lower following an overextended industry wide rally as well as highly questionable cabinet nominations by president elect Donald Trump.

Although the recent downward trend is concerning, this weakness has created an opportunity for investors to purchase high quality cannabis investments at a considerable discount.

Is British Sugar's 18 Hectare Grow-Op for $GWPH, just 20th Century Pig Farming?

Do we really think that modern pharmaceutical ingredients will be grown in massive grow-ops, subject to mold, fungus and pesticides? Considering other modern Bio-pharm technologies exists why farm plants? Solving ingredient supply, will become increasingly more problematic for Cannabis Pharmaceuticals companies as they move from the research lab to the pharmacy.